[1]
M. Hasbi, B. Loebis, V. Camellia, and E. Effendy, “Differences between Tumor Necrosis Factor-Alpha Levels and Interleukin-2 Levels in people with schizophrenia who get risperidone drugs in the acute phase of treatment in the Prof. DR. M. Ildrem Psychiatric Hospital, Medan”, Open Access Maced J Med Sci, vol. 9, no. T3, pp. 232–236, Jun. 2021.